ESTRO meets Asia_Programme Book_2018

Saturday 8 December 2018 (13:25-14:10)

ASTRAZENECA

ROOM TOPAZ Here and Now: New Treatment Option for Unresectable Stage III NSCLC Chairs: • Yasumasa Nishimura, MD, PhD, Radiation Oncologist, Kindai University, Japan • Shankar Siva, MD, PhD, Radiation Oncologist, Peter MacCallum Cancer Centre, Australia • Daniel Tan, MD, PhD, Symposium Chair, Medical Oncologist, National Cancer, Centre Singapore, Singapore

13:25-13:35

> Immunotherapy Overview and Importance of Multidisciplinary Care Daniel Tan, MD, PhD, Symposium Chair National Cancer Centre Singapore, Singapore > Overview of Treatment Landscape for Unresectable Stage III NSCLC Yasumasa Nishimura, MD, PhD Radiation Oncologist, Kindai University, Japan > Immunotherapy Approaches in Unresectable Stage III NSCLC Shankar Siva, MD, PhD Radiation Oncologist, Peter MacCallum Cancer Centre, Australia

13:35-13:45

13:45-14:00

14:00-14:10

> Question and Answer Session

Daniel Tan, MD, PhD, Symposium Chair National Cancer Centre Singapore, Singapore Summary and Closing Remarks Daniel Tan, MD, PhD, Symposium Chair National Cancer Centre Singapore, Singapore

14:10

>

Visit AstraZeneca, booth #54 for more information

SATELLITE SYMPOSIA | Programme and Exhibition Guide

76